Used in pharmaceutical research as an intermediate for synthesizing bioactive compounds targeting central nervous system disorders. Shows potential in the development of antidepressants and anxiolytic agents due to its structural affinity with serotonin and norepinephrine reuptake inhibitors. Employed in studies evaluating blood-brain barrier permeability because of its lipophilic-aromatic framework. Also utilized in controlled-release formulations where the ester moiety allows for gradual hydrolysis and sustained active metabolite release. Common in preclinical assays for receptor binding affinity screening, particularly at adrenergic and monoaminergic receptors.